| Course | NURS 6521 Advanced Pharmacology |
|---|---|
| Week | Week 4 |
| Paper type | Discussion post with two peer replies |
| Length | About 620 words, 4 pages |
| Format | Discussion post, APA 7 citations |
| School | Walden University |
| Program | Master of Science in Nursing (MSN) |
| Updated | October 2026 |
Free sample paper for NURS 6521 Week 4
Week 4 Discussion: Initial Post
Stepping Up From Albuterol Alone: An Inhaled Corticosteroid for Uncontrolled Asthma in a 24-Year-Old
My patient is fictional. T.N. is a 24-year-old graduate student with asthma since childhood who uses only an albuterol inhaler. Over the past three months she has needed it four or five days a week, wakes coughing about once a week, and stopped her evening runs because they bring on wheeze. Her last prescription for a controller was in high school, and she did not refill it.
Using the Global Initiative for Asthma control questions, she has daytime symptoms more than twice a week, night waking, reliever use more than twice a week, and activity limitation: all four criteria, so her asthma is uncontrolled. With symptoms most days and weekly night waking, GINA's current strategy places her at Step 3, and it no longer recommends treating adults with a short-acting beta agonist alone at any step (Global Initiative for Asthma [GINA], 2024). She has outgrown reliever-only treatment. The regimen I would choose is the GINA Track 1 option at Step 3: low-dose budesonide-formoterol taken daily and also as her reliever, replacing albuterol.
The reason is mechanism. Asthma is an inflammatory disease of the airway, and albuterol does nothing about the inflammation; it relaxes smooth muscle for a few hours and lets the underlying disease continue. Inhaled corticosteroids enter airway cells, bind the glucocorticoid receptor, and switch off transcription of inflammatory genes for cytokines, chemokines, and adhesion molecules, while reducing eosinophils and mast cells in the airway wall (Barnes, 2010). That reduces airway hyperresponsiveness and exacerbations over weeks. Formoterol is a long-acting beta agonist with a rapid onset, which is why it can serve as a reliever, and each reliever dose also delivers corticosteroid when her symptoms are worst. A long-acting bronchodilator on its own would be the wrong step up: it relieves symptoms while leaving inflammation untreated, and in a large trial salmeterol without an inhaled corticosteroid was associated with a small increase in asthma-related deaths (Nelson et al., 2006).
Two practical points come before the prescription. I would watch her use her inhaler, since poor technique is a common reason for apparent failure, and I would give her a written asthma action plan explaining what to do when symptoms rise and when to seek urgent care. Review in two to three months decides whether to step down or adjust.
Reply to Samantha
Samantha, your 66-year-old former smoker with daily breathlessness and a post-bronchodilator FEV1/FVC below 0.70 is a COPD patient, and I think that changes the pathway you applied. You started an inhaled corticosteroid first, which is the asthma logic. In COPD, the Global Initiative for Chronic Obstructive Lung Disease recommends starting with long-acting bronchodilators, and an inhaled corticosteroid is added mainly for patients with exacerbations and a raised blood eosinophil count, because the inflammation in COPD responds less to steroids and inhaled corticosteroids raise the risk of pneumonia (Global Initiative for Chronic Obstructive Lung Disease [GOLD], 2024). Did your patient have any exacerbations in the past year? That answer would decide whether the steroid belongs in his regimen at all.
Reply to Brandon
Brandon, you stepped your 17-year-old up to a medium-dose inhaled corticosteroid after two uncontrolled visits. Before escalating, I would want to know whether her technique had been checked and whether she was actually using the controller. GINA lists incorrect technique, poor adherence, and ongoing exposures such as smoke or allergens as the first things to review before stepping up (GINA, 2024). A higher dose delivered to the back of her throat instead of her lungs adds side effects without adding control. You mentioned her symptoms are worse in spring; does she also wake at night, and has anyone asked about pets or smoking at home?
References
Barnes, P. J. (2010). Inhaled corticosteroids. Pharmaceuticals, 3(3), 514-540. https://doi.org/10.3390/ph3030514
Global Initiative for Asthma. (2024). Global strategy for asthma management and prevention. https://ginasthma.org/2024-report/
Global Initiative for Chronic Obstructive Lung Disease. (2024). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2024 report. https://goldcopd.org/2024-gold-report/
Nelson, H. S., Weiss, S. T., Bleecker, E. R., Yancey, S. W., & Dorinsky, P. M. (2006). The Salmeterol Multicenter Asthma Research Trial: A comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest, 129(1), 15-26. https://doi.org/10.1378/chest.129.1.15
NURS 6521 Week 4 instructions, in plain terms
The fourth NURS 6521 thread asks you to recommend a step in inhaled therapy for a patient. Assess control with a named tool, choose the next step with reasons, explain how the drugs work and plan education and follow-up. The initial post carries most of the weight, and within it the reasoning for the step. Cite GINA or NAEPP guidance in APA 7. The example uses GINA, which no longer recommends albuterol alone. Replies can contrast related conditions such as COPD. The patient is fictional. Name the control criteria she meets. Open with the control assessment, then state the step, explain the drugs and close with education and follow-up. Replies can test a classmate's step against the same control questions.
How this NURS 6521 Week 4 example is built
The initial post runs about four hundred words in four paragraphs. The first gives the case in three sentences: symptom frequency, night waking and reliance on a short-acting beta agonist. The second classifies control and names the step the patient has outgrown, citing the stepwise model from the Global Initiative for Asthma. The third explains the controller's mechanism, an inhaled corticosteroid suppressing airway inflammation rather than opening the airway, and why the post rules out a long-acting bronchodilator on its own. The fourth covers inhaler technique and a written action plan. Two replies follow at roughly half the length. One addresses a classmate's COPD patient and explains why that pathway differs; the other questions whether a classmate's patient was stepped up before technique was checked.
Reading the NURS 6521 Week 4 rubric
Points for this thread are normally divided among the initial post, the replies and timeliness, with the initial post weighted most. Within it, the heaviest weight goes to rationale: naming a controller earns little unless the post explains what it does that the reliever does not. A common loss is escalation without assessment, where the post jumps to a stronger regimen without first rating control or checking technique. Evidence counts, and a stepwise model cited accurately outperforms a general textbook reference. A reply is credited for the pharmacology it adds, not for praise, so one confirming a classmate's choice without a new point scores thinly. Posting deadlines are often graded apart from content, which a late but strong post discovers.
Common NURS 6521 Week 4 mistakes, and how to avoid them
Inhaler posts score poorly when they add a drug without assessing control. Use the GINA questions. A second weakness is ignoring the change away from albuterol alone. Explain it. Writers also skip technique. Check it before stepping up. Avoid long lists of inhalers. Choose one regimen. Plan follow-up. A sentence explaining that inhaled corticosteroid treats the airway inflammation albuterol never touches shows why the step matters. Close with when you would reassess control. Name the inhaler device and how you will teach its use. Keep the main post on one patient and one step.
Get a NURS 6521 Week 4 example written to your instructions
Reply count, word limits and deadline rules all shape a thread, so include whatever your section states along with the prompt and rubric. Your Week 4 thread for NURS 6521 returns in 24 to 48 hours, initial post and both replies complete, with the first custom one free. Other respiratory conditions can replace the ones used in the replies.
More NURS 6521 papers and MSN samples
- NURS 6521 Week 1: Adverse Drug Event Review
- NURS 6521 Week 2: Prescriptive Authority Analysis
- NURS 6521 Week 3: Cardiovascular Drug Therapy Plan
- NURS 6521 Week 5: Antidiabetic class selection brief
- NURS 6521 Week 6: Gastrointestinal agent choice analysis
- NURS 6521 Week 7: Neurologic prescribing decision tree
- NURS 6521 Week 8: Hormonal agent risk discussion
- NURS 6521 Week 9: Antimicrobial stewardship rationale
- NURS 6521 Week 10: Drug interaction screening report
- NURS 6521 Week 11: Multisystem prescribing synthesis
- NURS 6630 Week 4: Mood disorder case
- NURS 6512 Week 4: Focused SOAP Note
- NURS 6710 Week 4: Community assessment
- NURS 6501 Week 4: Perfusion Case Study
NURS 6521 Week 4 questions, answered
Why does COPD appear in a reply rather than in the main post?
Because the prompt centers on one patient, and mixing a second disease into the main post would thin the argument for her. The COPD contrast still earns credit, so it appears where replies are graded, answering a classmate's case where the difference matters. If your prompt assigns COPD as the main condition, the post is rebuilt around that pathway instead.
Which guideline does the example cite?
The stepwise approach from the Global Initiative for Asthma, whose core premise is that therapy moves up or down in steps according to how well symptoms are controlled. Some sections prefer the national asthma guidance published in the United States instead. The example cites one model consistently rather than mixing both, and your section's preference decides which one appears.
Who is the woman with asthma in the post?
Nobody real is described. The woman in her twenties, her symptom pattern and her inhaler history were constructed so that the step-up decision would be clear-cut. Where your prompt supplies a case, the post uses only the details given, and where it asks for a patient from your practice, the details should be yours, with identifiers removed.
Where can I find a free NURS 6521 Week 4 sample paper?
The stepping up from albuterol post is reproduced here with the control assessment, the inhaled corticosteroid recommendation, mechanisms and replies.
Why is albuterol alone not enough in NURS 6521 Week 4?
Current guidance warns that reliever-only treatment leaves airway inflammation untreated and raises the risk of severe attacks.